Home Cart 0 Sign in  
X

[ CAS No. 3430-23-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 3430-23-7
Chemical Structure| 3430-23-7
Chemical Structure| 3430-23-7
Structure of 3430-23-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3430-23-7 ]

Related Doc. of [ 3430-23-7 ]

Alternatived Products of [ 3430-23-7 ]

Product Details of [ 3430-23-7 ]

CAS No. :3430-23-7 MDL No. :MFCD00128859
Formula : C6H5Br2N Boiling Point : -
Linear Structure Formula :- InChI Key :BNCGUATWCKZLLN-UHFFFAOYSA-N
M.W : 250.92 Pubchem ID :819338
Synonyms :

Calculated chemistry of [ 3430-23-7 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 44.6
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.98 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.16
Log Po/w (XLOGP3) : 2.6
Log Po/w (WLOGP) : 2.92
Log Po/w (MLOGP) : 2.33
Log Po/w (SILICOS-IT) : 3.18
Consensus Log Po/w : 2.64

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.53
Solubility : 0.0746 mg/ml ; 0.000297 mol/l
Class : Soluble
Log S (Ali) : -2.52
Solubility : 0.758 mg/ml ; 0.00302 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.12
Solubility : 0.019 mg/ml ; 0.0000757 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.39

Safety of [ 3430-23-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362+P364-P403+P233-P501 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3430-23-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3430-23-7 ]
  • Downstream synthetic route of [ 3430-23-7 ]

[ 3430-23-7 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 625-92-3 ]
  • [ 74-88-4 ]
  • [ 3430-23-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 20, p. 3009 - 3013
[2] Patent: US2007/185187, 2007, A1, . Location in patent: Page/Page column 9
  • 2
  • [ 74-88-4 ]
  • [ 3430-23-7 ]
Reference: [1] Patent: US2006/4000, 2006, A1, . Location in patent: Page/Page column 13
  • 3
  • [ 625-92-3 ]
  • [ 74-88-4 ]
  • [ 3430-23-7 ]
  • [ 125419-80-9 ]
Reference: [1] Tetrahedron Letters, 1996, vol. 37, # 15, p. 2565 - 2568
  • 4
  • [ 625-92-3 ]
  • [ 74-88-4 ]
  • [ 3430-23-7 ]
Reference: [1] Tetrahedron Letters, 1996, vol. 37, # 15, p. 2565 - 2568
  • 5
  • [ 3430-23-7 ]
  • [ 68-12-2 ]
  • [ 351457-86-8 ]
YieldReaction ConditionsOperation in experiment
72%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -100℃; for 0.0833333 h;
Stage #2: at -100 - -78℃; for 1.33333 h;
Stage #3: With ammonium chloride In tetrahydrofuran; hexane; waterSaturated solution
(a) Intermediate 1a: δ-Bromo^-methyl-pyridine-S-carbaldehyde:; 3,5-Dibromo-4-methyl-pyridine (3.8 g, 15.1 mmol) C1 was stirred in dry THF (150 mL) at -1000C(N2/ether) under argon. n-Butyllithium (2.5 M in hexanes, 6.2 mL, 15.4 mmol) was added dropwise, and the reaction stirred for 5 minutes DMF (1.8 mL, 23.2 mmol) was added, and the reaction was stirred for 20 minutes at -100 0C and then for 1 hour at -78 0C. The reaction was quenched with sat. NH4CI and extracted with ether. Organics were washed with brine, dried over Na2SO4, and concentrated in vacuo. Purification by silica gel chromatography (20percent ethyl acetate/hexanes) gave 2.18 g (72percent) of intermediate 1a as a clear oil which slowly solidified. 1H NMR (300 MHz, CDCI3) δ 10.25 (s, 1 H), 8.84 (s, 1H), 8.83 (s, 1H), 2.76 (s, 3H). Anal. (C7H6BrNO) C, H, N.
Reference: [1] Patent: WO2006/54151, 2006, A1, . Location in patent: Page/Page column 8
[2] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 15, p. 4297 - 4302
  • 6
  • [ 109-72-8 ]
  • [ 3430-23-7 ]
  • [ 351457-86-8 ]
Reference: [1] Patent: US2011/34441, 2011, A1,
  • 7
  • [ 3430-23-7 ]
  • [ 105-56-6 ]
  • [ 890092-52-1 ]
Reference: [1] Organic Letters, 2012, vol. 14, # 14, p. 3644 - 3647
  • 8
  • [ 3430-23-7 ]
  • [ 890092-52-1 ]
Reference: [1] Patent: WO2012/148808, 2012, A1, . Location in patent: Page/Page column 56
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 3430-23-7 ]

Bromides

Chemical Structure| 29976-20-3

[ 29976-20-3 ]

3,5-Dibromo-2,4-dimethylpyridine

Similarity: 0.92

Chemical Structure| 3430-25-9

[ 3430-25-9 ]

2,3,5-Tribromo-4-methylpyridine

Similarity: 0.88

Chemical Structure| 38749-87-0

[ 38749-87-0 ]

3,5-Dibromo-2-methylpyridine

Similarity: 0.85

Chemical Structure| 625-92-3

[ 625-92-3 ]

3,5-Dibromopyridine

Similarity: 0.84

Chemical Structure| 70201-42-2

[ 70201-42-2 ]

3,5-Dibromoisonicotinaldehyde

Similarity: 0.83

Related Parent Nucleus of
[ 3430-23-7 ]

Pyridines

Chemical Structure| 29976-20-3

[ 29976-20-3 ]

3,5-Dibromo-2,4-dimethylpyridine

Similarity: 0.92

Chemical Structure| 3430-25-9

[ 3430-25-9 ]

2,3,5-Tribromo-4-methylpyridine

Similarity: 0.88

Chemical Structure| 38749-87-0

[ 38749-87-0 ]

3,5-Dibromo-2-methylpyridine

Similarity: 0.85

Chemical Structure| 625-92-3

[ 625-92-3 ]

3,5-Dibromopyridine

Similarity: 0.84

Chemical Structure| 70201-42-2

[ 70201-42-2 ]

3,5-Dibromoisonicotinaldehyde

Similarity: 0.83